CARLSBAD, Calif. , Dec. 02, 2021 — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has retained PRIA Healthcare to assist in patient access for its proprietary products, including ZIP® and SiLOTM.
PRIA has 10 years of experience assisting medtech companies and their products with various payors to improve patient access to new medical devices. PRIA works with their clients to develop a patient based prior authorization and appeals program that leverages clinical evidence and historical coverage decisions to best inform payors about the individual patient story. PRIA is a relentless advocate, dedicated to helping patients avoid the pitfalls of today’s medical insurance systems, helping more patients gain access to the care most likely to benefit them.
Mr. Clay Schwabe, VP, Business Development of PRIA Healthcare Management, stated, “From the beginning of our relationship with Aurora Spine, I’ve been very impressed with their patient-focused mission, and how it resonates throughout the organization. From Trent, and his leadership team, to the field executives who work directly with their physician customers, Aurora is a true partner to the spine and pain management community. We’re excited to advocate on the behalf of patients to increase access to the products and procedures that have the greatest probability of reducing pain and increasing quality of life.”
Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, “We are excited to be working with PRIA as they help Aurora expand its products into the marketplace by working with many different insurance companies and educating them on the benefits of emerging medical technologies like those developed by Aurora. We have confidence in PRIA as they have successfully assisted other medtech companies that offer products similar to Aurora’s products.”
About PRIA
Since 2012, PRIA Healthcare has been a national leader in reimbursement and market access to the healthcare arena throughout the United States. Led by a team of industry veterans, PRIA is committed to ensuring the latest medical technologies and procedures are available to patients both during clinical trials and through product commercialization. PRIA diligently works to influence payers to establish patient access to life changing devices, therapies, treatments, and procedures by leveraging clinical data, patient, and physician rights.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
Adam Lowensteiner
LYTHAM PARTNERS, LLC
Phoenix | New York
Telephone: 646-829-9700
